Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were confirmed speakers for the 2020 Series.

Alan Smith

Executive Vice President, Technical Operations

Bellicum Pharmaceuticals

Alex Bloom

Vice President Regulatory Affairs and Quality Assurance

Gyroscope Therapeutics

Aline Hughson

Senior Process Scientist

Gyroscope Therapeutics

Andreas Unsoeld

Head of Cell Culture Media

Boehringer Ingelheim Corporate Center GmbH

Angela Columbano

Head of Business Development & Partnering

Genethon

Annie Hubert

Senior Director, EU Section & Public Policy

Alliance for Regeneratice Medicine

Anthony Ting

Vice President of Regenerative Medicine, Head of Cardiopulmonary Programs

Athersys

Ashish Dugar

Vice President, Global Medical Affairs

Sarepta Therapeutics

Asli Akidil

Senior Scientist, Oncology Safety Combinations

AstraZeneca

Axel Böhnke

Director Market Access EU North

PTC Therapeutics

Benjamin Moritz

Principal Scientist - Process Sciences

Ichnos Sciences SA

Benoit Moreaux

Chief Scientific and Technological Officer

Bone Therapeutics

Björn-Philipp Kloke

Early Development Leader - Cell & Gene Therapy

GlaxoSmithKline

Bo Kara

Vice President Process Development

Evox Therapeutics

Bobby Gaspar

Chief Executive Officer

Orchard Therapeutics

Britta Anderson

Senior R&D Scientist, Biopharmaceutical Expression Systems Team

Merck KGaA

Chaminda Salgado

Scientific leader, Cell & Gene Therapy Platform CMC

GlaxoSmithKline

Chris Bond

Vice President, Cell ular Engineering

Kite, A Gilead Company

Chris Heery

Chief Medical Officer

Precision BioSciences

Daniele Perna

Associate Fellow, Investigator Disruptive Technologies

GlaxoSmithKline

David James

Professor of Bioprocess Engineering

University of Sheffield

David Kim

Director, Global Supply Chain

Kite Pharma

David Moss

Group Leader: Development Scientist (DSP)

Adaptimmune

Donna McLaren

Senior Director

Orchard Therapeutics

Dusko Ilic

Professor of Stem Cell Science

King's College London

Elena Armenteros Monterroso

Lead Translational Scientist

UCL Institute of Child Health

Eleni Chantzoura

Associate Director, Immune Receptor Discovery

AgenTus Therapeutics

Erin Kimbrel

Executive Director of Regenerative Medicine

Astellas

Federico Mingozzi

Chief Scientific Officer

Spark Therapeutics

Francis Szele

Associate Professor of Developmental Biology

University of Oxford

Frank Thielmann

Operational Excellence Director - Region Europe

Takeda

Hans Keirstead

Chief Executive Officer

Aivita Biomedical

Hans-Juergen Fuelle

Global Therapeutic Area Lead RA Pharmaceuticals GDD, NIBR DA Lead OPH & DAx for Early Development Regulatory Affairs

Novartis

Hy Levitsky

President of Research & Development

Century Therapeutics

Igor Rudychev

Head of Data & Innovations, Global Commercial Innovation

AstraZeneca

Jacob Sten Peterson

Corporate Vice President

Novo Nordisk

Jak Knowles

Vice President, Venture Investments

Bayer

Janet Glassford

Senior Quality Assessor, Biological/Biotechnology Unit

MHRA

Joachim Baer

Director, Cell Culture Development

Boehringer Ingelheim Corporate Center GmbH

Joanna Kawalkowska

Senior Scientist - Cell & Gene Therapy

GammaDelta Tx

John Rossi

Senior Director, Head of Cell Therapy Clinical Pharmacology

Kite, A Gilead Company

Jolanda Gerritsen

Assistant Director, Cell Line Development

Genmab

Jonathan Collins

Senior Downstream Process and Technical Transfer Expert Manufacturing Science and Technology

Novartis

Jonathon Orme

Global Head of Cell Banking

AstraZeneca

Keith Life

Senior Director of Gene Therapy manufacturing

Biomarin

Knut Niss

Chief Technical Officer

Mustang Bio

Kyle Grant

Associate Director of Vector Production

Voyager Therapeutics

Laure Twyffels

Senior Scientist, R&D

Celyad

Laurence Guianvarc’h

Head of Upstream Process Development

Novartis

Lawrence Thompson

Senior Principal Scientist

Pfizer

Len Pattenden

Head of Biotherapeutics Development & Drug Supply

Cancer Research UK

Lior Raviv

Vice President

Pluristem

Lisa Mohamet

Scientific Director & Fellow, Functional Genomics

GlaxoSmithKline

Lydia Teboul

Head of Molecular & Cellular Biology

MRC Harwell

Manuel Carrondo

Vice President

Instituto de Biologia Experimental e Tecnologica

Marina Tarunina

Research Director

Plasticell

Mark Chen

Manager, Cell Line Development, Cell and Gene Therapy Product Development

GlaxoSmithKline

Mark Yang

Director

Genzyme

Matt Petroff

Senior Scientist

Spark Therapeutics

Michael Boychyn

Vice President, Process Development

REGENXBIO

Michael Lanero Fidalgo

Chief Operations Officer

TreeFrog Therapeutics

Min Wei

Director/Fellow

AstraZeneca

Mohamed Essameldin Abdelgawad

Associate Professor and Group Leader

Inserm

Mohammed Asmal

Vice Presdient and Head of Clinical Research & Development

bluebird bio

Mona Bausch

Scientist, Perfusion / Cell Culture Media

Merck KGaA

Mukesh Mayani

Principal Scientist - Gene Therapy

Sanofi

Nicholas Forsyth

Professor of Stem Cell Biology

Keele University

Nick Li

Senior Director, Health Economics & Outcomes Research

uniQure

Nina Kotsopoulou

Vice President, Cell & Gene Therapy

Orchard Therapeutics

Palani Palaniappan

Senior Vice President, Technical Operations

Sarepta Therapeutics

Patrick Hanley

Director GMP for Immunotherapy

Children's National Medical Center

Pedro Campino

Director, Senior Global Regulatory Lead, Gene Therapies

CSL Behring

Peter Olagunju

Senior Vice President

FerGene

Petra Kaufmann

Vice President, R&D Translational Medicine

AveXis, A Novartis Company

Pilar Redondo

Site Head, Cell Therapy Technology Center

Takeda

Qasim Rafiq

Associate Professor

UCL

Qi Cai

Senior Scientist, Lead of Non-Viral Vector Delivery Project

Kite, A Gilead Company

Rahul Pradhan

Group Leader

Kymab

Regina Fritsche Danielson

Senior Vice President and Global Head of Research and Early Clinical Development, Cardiovascular, Renal and Metabolic Diseases

AstraZeneca

Rhiannon David

Associate Principal Scientist

AstraZeneca

Rolf Koehler

Group Head CLD1

Novartis

Ron Bates

Director

Bristol-Myers Squibb

Rosemary Versteegen

Chief Executive Officer

International Serum Industry Association (ISIA)

Sabine Cholsta

Chief Medical Officer

Triumvira Immunologics

Sakis Mantalaris

Professor of Biomedical Engineering

Georgia Institute of Technology

Samantha Vieira

Executive Director

Biogen

Sarah Snykers

QC Manager

Celyad

Saurabh Sen

Principal Scientist

Boehringer Ingelheim Corporate Center GmbH

Seshu Tyagarajan

CMC Team Leader

Novartis

Sharon Longhurst

Head of CMC

Immunicum

Shree Patel

Senior Vice President, Clinical Operations

Achilles Therapeutics

Simon Auslaender

Group Leader Molecular & Cell Line Development

F. Hoffmann-La Roche Ltd

Simon Briggs

Senior Technical Product Steward for Kymriah

Novartis

Stefan Haider

Associate Director, Upstream Development

Boehringer Ingelheim Corporate Center GmbH

Stefan Przyborski

Professor of Cell Technology

Durham University

Stefano Pluchino

Chief Scientific Officer

iSTEM Therapeutics

Stefanos Grammatikos

Vice President, Head of Biotech Sciences

UCB PHARMA SA

Steve Okada

Vice President and Head, Clinical Strategy, Regenerative Medicine

Takeda

Ta-Chun Hang

Senior Scientist

bluebird bio

Tania Incitti

Senior Research Scientist

AstraZeneca

Thierry Zeigler

Senior Director

Cellectis

Tony D’Amore

Vice President, Product Research & Development

Sanofi

Ulrich Ruemenapp

Head of Launch Preparation and Coordination

Bayer AG

Uwe Demelbauer

Global Head Drug Substance Development, Operational Sciences Mammalian

Novartis

Vincent Dewar

Lead Monoclonal Antibodies Platform, Senior Manager

GlaxoSmithKline

Ying Huang

Chief Financial Officer

Legend Biotech

Yun Tang

Head of Cell Therapy Development Operations

Juno Therapeutics

Yuval Shimoni

Principal Engineer

Bayer AG

: Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were confirmed speakers for the 2020 Series.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Cell Series 2019Post-Event Report

Statistics, feedback, photos and more from last year's event

Cell Series 2019
Post-Event Report